Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANEX trial of tranexamic acid in burn excisional surgery
NL-OMON60497Phase 4Completed
- Sponsor
- Maasstad Ziekenhuis
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of tranexamic acid in burn injury, sponsored by Maasstad Ziekenhuis. Primary endpoints: Volume of blood loss and Extent of fibrinolysis. Started Nov 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
burn injury
Beyond the preview
Go deeper on NL-OMON60497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60497.